MAM
RGLS

Meeder Asset Management’s Regulus Therapeutics RGLS Stock Holding History

Meeder Asset Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-62
Closed -$4.9K – 1667
2018
Q2 		$4.9K Buy
62
+14
+29% +$1.16K ﹤0.01% 1281
2018
Q1 		$4K Sell
48
-27
-36% -$3.61K ﹤0.01% 1286
2017
Q4 		$9K Buy
75
+39
+108% +$4.94K ﹤0.01% 1159
2017
Q3 		$5K Buy
36
+24
+200% +$3.02K ﹤0.01% 1275
2017
Q2 		$1K Hold
12
– – ﹤0.01% 1547
2017
Q1 		$2K Sell
12
-61
-84% -$11.6K ﹤0.01% 1396
2016
Q4 		$20K Buy
+73
New +$23.7K ﹤0.01% 656

Other funds holding RGLS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return